Wagamaga OP t1_ir6j2h5 wrote
There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body’s immune system attacks the nerves, according to a Rutgers-led study.
Published in the journal Vaccine, a statistical analysis by a Rutgers-team found that there was not a significant association between any of the COVID-19 vaccinations currently offered and the disease. The team was led by Nizar Souayah, a professor of neurology at Rutgers New Jersey Medical School who mentored a group of Rutgers New Jersey Medical School students, in collaboration with other scientists.
In July 2021, the U.S. Food and Drug Administration issued a warning, based on early reports, that those receiving the Johnson & Johnson’s COVID-19 vaccine may be at a greater risk of developing the sometimes fatal disease.
Archy99 t1_ir8i06s wrote
From the conclusion:
>Although the reporting rate of GBS after COVID-19 vaccination was not
statistically different than that of the general population, the
increased reporting of GBS within the first 6 weeks after COVID-19
vaccination, more so than with other vaccinations, suggests that some
cases of GBS are temporally associated with COVID-19 vaccination.
However, there is a reduction in the reporting rate of GBS after other
vaccines, compared to reporting rates pre-COVID-19, highlighting
limitations inherent in any passive surveillance system. These findings
warrant continuous analysis of GBS after COVID-19 vaccination.
underbite420 t1_ir9gfhz wrote
Such a great summary that hasn’t been deleted
Viewing a single comment thread. View all comments